Non-malignant hematology Section Leader/Academic Rank/Depends on Qualifications

UNMC is an Equal Employment Opportunity Employer, including an equal opportunity employer of protected veterans and individuals with disabilities.

100

Non-malignant hematology Section Leader opportunity at UNMC
The Division of Hematology/Oncology at the University of Nebraska Medical Center (UNMC) in vibrant Omaha, NE, invites an ambitious and visionary Hematologist specializing in non-malignant hematology clinical care and research to lead our thriving Section. We seek a dynamic, collaborative academic leader with a track record of excellence in clinical practice, research, and mentorship to spearhead growth and innovation in this critical area.
This leadership role offers a unique opportunity to shape the future of non-malignant hematology at UNMC. The Section is poised to grow to 4-6 faculty members in the coming years. As the Section Leader, you’ll drive cutting-edge clinical care and transformative research while mentoring a multidisciplinary team committed to advancing patient outcomes.
Through collaboration with our hospital partner, Nebraska Medicine, patients experience personalized care based on the latest scientific research. With this opportunity you will enjoy participating in multidisciplinary patient care teams, inpatient treatment, outpatient care, clinical trials and opportunities for collaboration for investigator initiated clinical research, and translational research.
With this opportunity you will find:
• Cutting-Edge Care and Research: The Fred & Pamela Buffett Cancer Center, an NCI-designated cancer center in Nebraska, is a leader in patient care and research. Access advanced resources, including a 10-story research tower and an 8-story inpatient treatment center integrating clinical care, research, and education
• National Collaboration: Participate in the Big Ten Cancer Research Consortium, advancing team-based science to develop life-changing therapies.
• Cutting-Edge Research: As a founding member of the National Comprehensive Cancer Network (NCCN) and the Big Ten Cancer Research Consortium, you will lead a team of researchers in a dynamic environment, driving ideas from the lab to life-changing treatments.
• Innovative Collaboration: Join a groundbreaking team of over 200 oncologists, translational researchers, and basic scientists who unite science and medicine to revolutionize cancer care.
Why Omaha?
Omaha is a vibrant, family-friendly city consistently ranked among the best places to live in the United States. It offers a low cost of living, excellent schools, and a thriving arts and culture scene. Whether you enjoy exploring the outdoors, indulging in the local culinary delights, or attending nationally recognized events, Omaha has something for everyone.

The successful candidate must be an MD/DO (or equivalent degree) who is board certified in medical oncology and/or hematology and possess a strong background in clinical and translational research. We seek a dynamic, collaborative academic leader with a track record of excellence in clinical practice, research, and mentorship to spearhead growth and innovation in this critical area. A devotion to clinical care and clinical investigation in non-malignant hematology, plus at least three years of experience, is preferred. Interest and experience in teaching fellows, residents, and medical students is required.

Our compensation package is extremely competitive and includes comprehensive benefits, generous employer paid retirement contributions, CME funding and time, and paid time off.

Candidates interested in learning more about this opportunity should contact:

Julie Vose, MD, MBA
jmvose@unmc.edu
For immediate consideration, apply online at https://unmc.peopleadmin.com/postings/91618.

MD, DO, or MBBS degree, board certification in Internal Medicine and be board certified/eligible in medical oncology and/or hematology.

Full extent of working environment TBD by patient care, research, and teaching activity.

Full extent of exposures TBD by patient care, research, and teaching activity.

Full extent of hand/wrist TBD by patient care, research, and teaching activity